Aberrant promoter methylation of the vimentin gene in colorectal cancer associated with the adenoma-carcinoma Sequence

Korean Journal of Pathology

Volumn 44, Issue 2, 2010, Pages 179-186

  Cho, Mi Hee ^a   Lee, Yu Mi ^a   Kim, Jin Sook ^a   Kim, Hyun Soo ^a   Lee, Kyung Hwa ^a   Juhng, Sang Woo ^a   Lee, Jae Hyuk ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Colorectal neoplasms; Methylation; Polymerase chain reaction; Vimentin

Indexed keywords

EID: 77955023419     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2010.44.2.179     Document Type: Article

References (29)

1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32.
2. Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996; 13: 343-6.
3. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6: 107-16.
4. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001; 61: 4689-92.
5. Harris LC, Potter PM, Tano K, Shiota S, Mitra S, Brent TP. Characterization of the promoter region of the human O6-methylguanine- DNA methyltransferase gene. Nucleic Acids Res 1991; 19: 6163-7.
6. Kim HC, Roh SA, Ga IH, Kim JS, Yu CS, Kim JC. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 2005; 20: 1920-6.
7. Bloemendal H, Pieper FR. Intermediate filaments: known structure, unknown function. Biochim Biophys Acta 1989; 1007: 245-53.
8. Lodish H, Baltimore D, Berk A, Zipursky SL, Mastudaira P, Darnell J. Molecular cell biology. 3rd ed. New York: Scientific American Books, 1995.
9. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988; 57: 593-625.
10. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997; 150: 1547-52.
11. Ministry for Health, Welfare, and Family Affairs. Statistical year-book of Ministry for Health, Welfare, and Family Affairs: cancer incidence and major cancer five-year relative survival. Seoul: Ministry for Health, Welfare, and Family Affairs, 2008.
12. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-17.
13. Kim H. Clinical and pathological significance of the genetic analysis in colorectal carcinomas. Korean J Gastroenterol 2004; 43: 275- 82.
14. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000; 119: 854-65.
15. Bestor TH, Ingram VM. Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc Natl Acad Sci U S A 1983; 80: 5559-63.
16. Huang TH, Perry MR, Laux DE. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999; 8: 459-70.
17. Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 1994; 94: 491-6.
18. Graff JR, Herman JG, Lapidus RG, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55: 5195-9.
19. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-sup-pressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994; 91: 9700-4.
20. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-40.
21. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808-11.
22. Brenner DE, Rennert G. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? J Natl Cancer Inst 2005; 97: 1107-9.
23. Chen WD, Han ZJ, Skoletsky J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97: 1124-32.
24. Zou H, Harrington JJ, Shire AM, et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 2007; 16: 2686-96.
25. Ngan CY, Yamamoto H, Seshimo I, et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer 2007; 96: 986-92.
26. Singh S, Sadacharan S, Su S, Belldegrun A, Persad S, Singh G. Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res 2003; 63: 2306-11.
27. Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005; 5: 2602-11.
28. Bindels S, Mestdagt M, Vandewalle C, et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006; 25: 4975-85.
29. Yates B, Zetterberg C, Rajeev V, Reiss M, Rittling SR. Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta. Exp Cell Res 2007; 313: 3718-28.